Workflow
百奥泰(688177) - 2024 Q3 - 季度财报
688177Bio-Thera(688177)2024-10-29 08:28

Investment Activities - Investment activities generated a net cash flow of 67.45 million yuan, compared to 140.08 million yuan in the same period last year[34] - Cash inflows from investment activities totaled 904.44 million yuan, a decrease from 1.56 billion yuan in the previous year[34] - Cash outflows from investment activities amounted to 836.99 million yuan, down from 1.42 billion yuan in the prior year[34] - The company invested 740 million yuan in investments, compared to 1.19 billion yuan in the same period last year[34] Financing Activities - Cash inflows from financing activities were 375.05 million yuan, compared to 427.47 million yuan in the same period last year[34] - Cash outflows from financing activities totaled 214.71 million yuan, a significant increase from 30.65 million yuan in the previous year[34] - Net cash flow from financing activities was 160.34 million yuan, down from 396.82 million yuan in the prior year[34] Cash and Cash Equivalents - The net increase in cash and cash equivalents was 142.01 million yuan, compared to 179.04 million yuan in the same period last year[34] - The ending balance of cash and cash equivalents was 256.95 million yuan, down from 322.08 million yuan in the previous year[34] Capital Expenditures - The company spent 96.99 million yuan on the purchase of fixed assets, intangible assets, and other long-term assets, a decrease from 227.88 million yuan in the prior year[34]